Patents by Inventor Martin Lindberg

Martin Lindberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6100055
    Abstract: DNA molecules and methods for producing proteins, or fragments thereof, having binding activity for the fast form of .alpha..sub.2 -macroglobulins as exemplified for the streptococcal surface proteins MIG, MAG and ZAG.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: August 8, 2000
    Inventors: Bengt Guss, Hans Jonsson, Martin Lindberg, Hans-Peter Mueller, Liisa K. Rantamaki
  • Patent number: 6086895
    Abstract: The present invention relates to new recombinant DNA-molecules comprising nucleotide sequences of S. dygalactiae encoding for at least one protein or polypeptide having fibronectin binding property.
    Type: Grant
    Filed: August 1, 1997
    Date of Patent: July 11, 2000
    Assignee: Alfa Laval Agri International
    Inventors: Magnus Hook, Kjell Martin Lindberg, Per-Eric Lindgren, Lars Christer Signas
  • Patent number: 5980908
    Abstract: The invention is concerned with a vaccine composition comprising an effective amount of an isolated protein derived from Staphylococcal aureus having the ability to bind fibronectin. The protein has a molecular weight of 165,000 daltons and optionally also contains a protein having a molecular weight of 87,000 daltons. The protein has the ability to elicit antibody production and a level of protein to elicit antibody production. The level of protein is sufficient to produce protection upon challenge with a Staphylococcus aureus bacterial strain in a mammal, particularly a ruminant, by forming antibodies against the Staphylococcus aureus bacterial strain.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: November 9, 1999
    Assignee: Alfa Laval AB
    Inventors: Magnus Hook, Kjell Martin Lindberg, Torkel Mikael Wadstrom
  • Patent number: 5866541
    Abstract: The present invention relates to new recombinant DNA-molecules comprising nucleotide sequences of S. dysgalactiae encoding for at least one protein or polypeptide having fibronectin binding property.
    Type: Grant
    Filed: April 25, 1995
    Date of Patent: February 2, 1999
    Assignee: Alfa-Laval Agri International Aktiebolag
    Inventors: Magnus Hook, Kjell Martin Lindberg, Per-Eric Lindgren, Lars Christer Signas
  • Patent number: 5851794
    Abstract: The present invention relates to a new recombinant DNA-molecule comprising a nucleotide sequence from S. aureus coding for a protein, or polypeptide, having collagen binding properties.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: December 22, 1998
    Assignee: Alfa Laval AB
    Inventors: Bengt Guss, Magnus Hook, Hans Jonsson, Martin Lindberg, Joseph Patti, Christer Signas, Lech Switalski
  • Patent number: 5840846
    Abstract: The present invention relates to a new recombinant hybrid-DNA-molecule comprising a nucleotide sequence from S. aureus coding for a protein, or polypeptide, having fibronectin binding properties.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: November 24, 1998
    Assignee: Alfa-Laval Agri International Aktiebolag
    Inventors: Magnus Hook, Klas Jonsson, Kjell Martin Lindberg, Christer Signas
  • Patent number: 5789549
    Abstract: The present invention relates to new recombinant DNA-molecules comprising nucleotide sequences of S. dysgalactiae encoding for at least one protein or polypeptide having fibronectin binding property.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: August 4, 1998
    Assignee: Alfa Laval Agri International Aktiebolag
    Inventors: Magnus Hook, Kjell Martin Lindberg, Per-Eric Lindgren, Lars Christer Signas
  • Patent number: 5652217
    Abstract: The present invention relates to a new recombinant hybrid-DNA-molecule comprising a nucleotide sequence from S. aureus coding for a protein, or polypeptide, having fibronectin binding properties.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: July 29, 1997
    Assignee: Alfa-Laval Agri International Aktiebolag
    Inventors: Magnus Hook, Klas Jonsson, Kjell Martin Lindberg, Christer Signas
  • Patent number: 5100788
    Abstract: A method of producing and selectively isolating a desired protein or polypeptide or derivative thereof by constructing a recombinant vector comprising a DNA sequence coding for said desired protein or polypeptide operatively linked to a DNA sequence coding for protein A or an active polypeptide fragment thereof or any other macromolecule capable of binding to the constant regions of immunoglobulins, such that said DNA sequences together code for an IgG-binding fusion product between said desired protein or polypeptide and said protein A, active polypeptide fragment thereof or macromolecule; transforming a compatible host with said recombinant vector such that the combined DNA sequences coding for said fusion protein or polypeptide can be expressed by the host, and culturing the transformed host in a suitable growth medium to produce said fusion protein or polypeptide; selectively isolating said fusion protein or polypeptide by adsorption to an IgG-supporting carrier material; and optionally desorbing said fus
    Type: Grant
    Filed: May 9, 1988
    Date of Patent: March 31, 1992
    Assignee: Pharmacia LKB Biotechnology AB
    Inventors: Sven Lofdahl, Mathias Uhlen, Martin Lindberg, John Sjoquist